Type I interferon regulation of natural killer cell function in primary and secondary infections

被引:16
|
作者
Stackaruk, Michele L. [1 ]
Lee, Amanda J. [1 ]
Ashkar, Ali A. [1 ]
机构
[1] McMaster Univ, McMaster Immunol Res Ctr, Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON L8S 4K1, Canada
关键词
adjuvants; dendritic cell vaccines; innate; natural killer cells; natural killer cell memory; type I interferon; vaccine; viral infection; CHRONIC HEPATITIS-C; MOUSE LYMPHOID-CELLS; NK-CELLS; DENDRITIC CELLS; IMMUNE-RESPONSES; IFN-GAMMA; CYTOTOXIC REACTIVITY; ALLOGENEIC TUMORS; DISTINCT ROLES; CUTTING EDGE;
D O I
10.1586/14760584.2013.814871
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The priming of natural killer (NK) cells by type I interferon (IFN) is necessary for protection against primary and secondary viral infections. However, the pathway by which type I IFN activates NK cells to elicit antiviral responses is controversial. There is evidence to suggest that type I IFN priming of NK cells occurs through both direct and indirect pathways. As with many innate mechanisms, type I IFN and NK cells also orchestrate the adaptive immune response and thus aid in protection against secondary infections. Type I IFN can shape CD4(+) T cell, B cell and humoral memory formation. In addition, long-lived NK cells can perform specific and enhanced memory-like protection in secondary infections. This review outlines the different mechanisms underlying type I IFN regulation of NK cells and how type I IFN and NK cells can be used as a therapeutic target in vaccinations.
引用
收藏
页码:875 / 884
页数:10
相关论文
共 50 条
  • [1] Interferon type I responses in primary and secondary infections
    Alsharifi, Mohammed
    Muellbacher, Arno
    Regner, Matthias
    IMMUNOLOGY AND CELL BIOLOGY, 2008, 86 (03): : 239 - 245
  • [2] Interferon type-I responses in primary and secondary viral infections
    Alsharifi, Mohammed
    Regner, Matthias
    Blanden, Robert
    Lobigs, Mario
    Lee, Eva
    Koskinen, Aulikki
    Muellbacher, Arno
    CYTOKINE, 2007, 39 (01) : 1 - 1
  • [3] Type I Interferons and Natural Killer Cell Regulation in Cancer
    Mueller, Lena
    Aigner, Petra
    Stoiber, Dagmar
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [4] Regulation of natural killer cell function
    Makrigiannis, AP
    Anderson, SK
    CANCER BIOLOGY & THERAPY, 2003, 2 (06) : 610 - 616
  • [5] NATURAL-KILLER CELL-FUNCTION AND INTERFERON GENERATION IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
    MESSINA, C
    KIRKPATRICK, D
    FITZGERALD, PA
    OREILLY, RJ
    SIEGAL, FP
    CUNNINGHAMRUNDLES, C
    BLAESE, M
    OLESKE, J
    PAHWA, S
    LOPEZ, C
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 39 (03): : 394 - 404
  • [6] Natural killer (NK) cell biology: Understanding regulation and function during viral infections
    Biron, CA
    PATHOLOGIE BIOLOGIE, 1998, 46 (02): : 134 - 134
  • [7] Neuroendocrine regulation of natural killer cell function.
    Morgan, FW
    Callewaert, DM
    FASEB JOURNAL, 1999, 13 (05): : A961 - A961
  • [8] Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells
    Barnes, Samantha A.
    Audsley, Katherine M.
    Newnes, Hannah V.
    Fernandez, Sonia
    de Jong, Emma
    Waithman, Jason
    Foley, Bree
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] MODE OF REGULATION OF NATURAL-KILLER CELL-ACTIVITY BY INTERFERON
    MINATO, N
    REID, L
    CANTOR, H
    LENGYEL, P
    BLOOM, BR
    JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (01): : 124 - 137
  • [10] REGULATION OF HUMAN NATURAL-KILLER-CELL ACTIVITY BY AN INTERFERON INHIBITOR
    CHEKNEV, SB
    NAROVLYANSKII, AN
    AMCHENKOVA, AM
    ERSHOV, FI
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1991, 112 (10) : 1454 - 1456